Decoy Therapeutics (DCOY) Net Margin (2016 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Net Margin of 599.23% for Q2 2021, down 44633.0% year-over-year from N/an in Q2 2020, and down 193.29% quarter-over-quarter from 204.31% in Q1 2021.
Decoy Therapeutics (DCOY) Net Margin (2016 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Net Margin for 6 consecutive years, with 599.23% the latest figure, recorded in Q2 2021.
- In Q2 2021, Net Margin fell 44633.0% year-over-year to 599.23%; the TTM figure through Mar 2022 stood at 3098.46% (down 298201.0% YoY), while the FY2021 annual figure was 693.84%, down 54578.0% from the prior year.
- Net Margin fell to 599.23% in Q2 2021 per DCOY's latest filing, from 204.31% in the prior quarter.
- Across five years, Net Margin topped out at 70.79% in Q3 2018 and bottomed at 4604.73% in Q1 2018.
- Historically, Net Margin has averaged 1320.2% across 5 years, with a median of 340.19% in 2019.
- Annual changes were most pronounced in 2017 — Net Margin surged 745983 bps — and 2018, when it plunged 119575 bps.
- Decoy Therapeutics' Net Margin stood at 2838.66% in 2017, then surged by 76 bps to 691.48% in 2018, then surged by 74 bps to 181.04% in 2019, then jumped by 34 bps to 118.96% in 2020, then sank by 404 bps to 599.23% in 2021.
- Business Quant data shows DCOY's Net Margin at 599.23% in Q2 2021, 204.31% in Q1 2021, and 118.96% in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 12.74% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.51% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -3.12% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 12.09% |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | -1,142.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,152.11% |
| Jun 30, 2021 | -599.23% |
| Mar 31, 2021 | -204.31% |
| Dec 31, 2020 | -118.96% |
| Jun 30, 2020 | -152.89% |
| Mar 31, 2020 | -209.44% |
| Dec 31, 2019 | -181.04% |
| Sep 30, 2019 | -300.60% |
| Jun 30, 2019 | -154.59% |
| Mar 31, 2019 | -340.19% |
| Dec 31, 2018 | -691.48% |
| Sep 30, 2018 | -70.79% |
| Jun 30, 2018 | -3,687.09% |
| Mar 31, 2018 | -4,604.73% |
| Dec 31, 2017 | -2,838.66% |
| Sep 30, 2017 | -2,256.31% |
| Jun 30, 2017 | -2,624.15% |
| Mar 31, 2017 | -3,408.99% |
| Dec 31, 2016 | -2,713.87% |
| Sep 30, 2016 | -1,775.66% |